Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Bellerophon Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −3 vs. Q1 2022
- Shares held
- 1.14M
- +676 (+0.1%) vs. Q1 2022
- Total value
- $1.40M
- −$1.28M (−47.8%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 6
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $6.37K |
| Q3 2023 | 22 | $506.6K |
| Q2 2023 | 23 | $824.9K |
| Q1 2023 | 19 | $27.9M |
| Q4 2022 | 25 | $832.7K |
| Q3 2022 | 19 | $1.18M |
| Q2 2022 | 19 | $1.40M |
| Q1 2022 | 22 | $2.68M |
| Q4 2021 | 22 | $3.82M |
| Q3 2021 | 22 | $4.81M |
| Q2 2021 | 27 | $6.34M |
| Q1 2021 | 39 | $10.9M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Bellerophon Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 253 | $0 | 0.00% | −2−0.8% | Reduced |
| JPMorgan Chase & Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,473 | $2.00K | 0.00% | −722−32.9% | Reduced |
| US Bancorp | 1,221 | $2.00K | 0.00% | 00.0% | Unchanged |
| Destination Wealth Management | 10,000 | $12.0K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 10,625 | $13.0K | 0.00% | +9,049+574.2% | Added |
| Susquehanna International Group, LLP | 14,335 | $18.0K | 0.00% | +14,335 | New |
| Tudor Investment Corp Et Al | 20,000 | $25.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,327 | $26.0K | 0.00% | 00.0% | Unchanged |
| Sepio Capital, LP | 23,800 | $29.0K | 0.00% | +23,800 | New |
| Northern Trust Corp | 28,097 | $35.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 64,355 | $79.0K | 0.00% | +6,014+10.3% | Added |
| Telemetry Investments, L.L.C. | 69,000 | $85.0K | 0.13% | −14,584−17.4% | Reduced |
| BlackRock Inc. | 100,625 | $124.0K | 0.00% | −20,064−16.6% | Reduced |
| Wells Fargo & Company | 200,057 | $246.0K | 0.00% | +50.0% | Added |
| Renaissance Technologies LLC | 209,399 | $258.0K | 0.00% | +24,100+13.0% | Added |
| Vanguard Group Inc | 360,790 | $443.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −37,327−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,075−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,571−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −86−100.0% | Sold out |